Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Should "indeterminate" diagnoses be used for thyroid fine-needle aspirates of nodules smaller than 1 cm?

Renshaw AA, Gould EW.

Arch Pathol Lab Med. 2013 Nov;137(11):1627-9. doi: 10.5858/arpa.2012-0575-OA.

PMID:
24168500
[PubMed - indexed for MEDLINE]
2.

Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.

Williams MD, Suliburk JW, Staerkel GA, Busaidy NL, Clayman GL, Evans DB, Perrier ND.

Ann Surg Oncol. 2009 Nov;16(11):3146-53. doi: 10.1245/s10434-009-0666-3.

PMID:
19727961
[PubMed - indexed for MEDLINE]
3.

Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?

Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW.

Diagn Cytopathol. 2006 May;34(5):330-4.

PMID:
16604553
[PubMed - indexed for MEDLINE]
4.

Follicular lesion of undetermined significance in thyroid FNA revisited.

Walts AE, Mirocha J, Bose S.

Diagn Cytopathol. 2014 Jan;42(1):18-22. doi: 10.1002/dc.23019. Epub 2013 Jul 27.

PMID:
23894017
[PubMed - indexed for MEDLINE]
5.

Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.

Ha EJ, Baek JH, Lee JH, Song DE, Kim JK, Shong YK, Hong SJ.

Thyroid. 2013 Jun;23(6):703-8. doi: 10.1089/thy.2012.0426. Epub 2013 May 28.

PMID:
23544697
[PubMed - indexed for MEDLINE]
6.

Predictors of malignancy in patients with cytologically suspicious thyroid nodules.

Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC.

Thyroid. 2011 Nov;21(11):1191-8. doi: 10.1089/thy.2011.0146. Epub 2011 Oct 18.

PMID:
22007937
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Thyroid nodule size and prediction of cancer.

Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, Benson CB, Doubilet PM, Cibas ES, Barletta J, Cho N, Gawande A, Ruan D, Moore FD Jr, Pou K, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2013 Feb;98(2):564-70. doi: 10.1210/jc.2012-2968. Epub 2012 Dec 28.

PMID:
23275525
[PubMed - indexed for MEDLINE]
8.

Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.

Saiegh L, Shechner C, Dickstein G, Sheikh-Ahmad M, Reut M, Odeh M, Toubi A, Bejar J.

Minerva Endocrinol. 2014 Mar;39(1):43-52.

PMID:
24513603
[PubMed - indexed for MEDLINE]
9.
10.

Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).

Ho AS, Sarti EE, Jain KS, Wang H, Nixon IJ, Shaha AR, Shah JP, Kraus DH, Ghossein R, Fish SA, Wong RJ, Lin O, Morris LG.

Thyroid. 2014 May;24(5):832-9. doi: 10.1089/thy.2013.0317. Epub 2014 Mar 10.

PMID:
24341462
[PubMed - indexed for MEDLINE]
11.

Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.

Batawil N, Alkordy T.

Eur J Surg Oncol. 2014 Feb;40(2):182-6. doi: 10.1016/j.ejso.2013.11.015. Epub 2013 Dec 14.

PMID:
24373298
[PubMed - indexed for MEDLINE]
12.

Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.

Goldstein RE, Netterville JL, Burkey B, Johnson JE.

Ann Surg. 2002 May;235(5):656-62; discussion 662-4.

PMID:
11981211
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.

Mihai R, Parker AJ, Roskell D, Sadler GP.

Thyroid. 2009 Jan;19(1):33-7. doi: 10.1089/thy.2008.0200.

PMID:
18976164
[PubMed - indexed for MEDLINE]
14.

Atypical follicular cells with equivocal features of papillary thyroid carcinoma is not a low-risk cytologic diagnosis.

Luu MH, Fischer AH, Stockl TJ, Pisharodi L, Owens CL.

Acta Cytol. 2011;55(6):526-30. doi: 10.1159/000333227. Epub 2011 Dec 9.

PMID:
22156461
[PubMed - indexed for MEDLINE]
15.

The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience.

Rossi ED, Straccia P, Martini M, Revelli L, Lombardi CP, Pontecorvi A, Fadda G.

Cancer Cytopathol. 2014 May;122(5):359-67. doi: 10.1002/cncy.21400. Epub 2014 Jan 28.

PMID:
24474727
[PubMed - indexed for MEDLINE]
16.

[The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].

Miseikyte-Kaubriene E, Ulys A, Trakymas M.

Medicina (Kaunas). 2008;44(3):189-94. Lithuanian.

PMID:
18413985
[PubMed - indexed for MEDLINE]
Free Article
17.

Correlation of thyroid fine-needle aspiration with final histopathology: a case series.

Gürkan Dumlu E, Kiyak G, Bozkurt B, Tokaç M, Polat B, Cakir B, Güler G, Kiliç M.

Minerva Chir. 2013 Apr;68(2):191-7.

PMID:
23612233
[PubMed - indexed for MEDLINE]
18.

Telomerase activity in "suspicious" thyroid cytology.

Lerma E, Mora J.

Cancer. 2005 Dec 25;105(6):492-7.

PMID:
16104043
[PubMed - indexed for MEDLINE]
Free Article
19.

Thyroid fine-needle aspiration cytology: performance data of neoplastic and malignant cases as identified from 1558 responses in the ASCP Non-GYN Assessment program thyroid fine-needle performance data.

Eilers SG, LaPolice P, Mukunyadzi P, Kapur U, Wendel Spiczka A, Shah A, Saleh H, Adeniran A, Nunez A, Balachandran I, Clark JJ, Lemon L.

Cancer Cytopathol. 2014 Oct;122(10):745-50. doi: 10.1002/cncy.21440. Epub 2014 Jun 9.

PMID:
24913410
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration.

Teixeira GV, Chikota H, Teixeira T, Manfro G, Pai SI, Tufano RP.

World J Surg. 2012 Jan;36(1):69-74. doi: 10.1007/s00268-011-1336-8.

PMID:
22057754
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk